Altra

Meet Jose Brizuela, the driving force behind operations at Altra as our Chief Operating Officer! With 10 years of expertise in medical device and plastic and manufacturing, Jose has a proven track record of leading startups from the drawing board to full-scale production. As a dual expert in product development and operations, Jose excels at streamlining processes and delivering high-quality results. With an M.E. in Polymer Science & Engineering from Lehigh University and an MBA from the Rady School of Management, Jose combines technical mastery with strategic business savvy to fuel growth and innovation. Excited to see the future Jose is building at Altra ! #COO #OperationsLeadership #Innovation #PolymerScience #Manufacturing #RadyMBA #MedTech

Exciting News! Altra, Inc. has been accepted into UC San Diego Venture Catalyst Program! This incredible opportunity will help us scale our impact in infusion therapy by providing essential support in key areas such as access to capital, coaching and mentorship, and connections to venture funds and funding vehicles. Altra is thrilled to join a community dedicated to empowering startups and SMEs, especially those led by women, veterans, BIPOC, disabled, and LGBTQIA+ entrepreneurs. Please visit this?page?for more information about UC San Diego Venture Catalyst Program. Here's to pushing boundaries and creating meaningful change in MedTech! https://lnkd.in/g4W7RMUm #UCSanDiego #VentureCatalystProgram #InfusionTherapy #MedTechInnovation #InclusiveGrowth

Exciting News! Altra, Inc. has been accepted into UC San Diego Venture Catalyst Program! This incredible opportunity will help us scale our impact in infusion therapy by providing essential support in key areas such as access to capital, coaching and mentorship, and connections to venture funds and funding vehicles. Altra is thrilled to join a community dedicated to empowering startups and SMEs, especially those led by women, veterans, BIPOC, disabled, and LGBTQIA+ entrepreneurs. Please visit this?page?for more information about UC San Diego Venture Catalyst Program. Here's to pushing boundaries and creating meaningful change in MedTech! https://lnkd.in/g4W7RMUm #UCSanDiego #VentureCatalystProgram #InfusionTherapy #MedTechInnovation #InclusiveGrowth

Thrilled to introduce Matthew S Morris, Chief Executive Officer at Altra! Through his 8 years working with the Altra team, he has cultivated a unique understanding of the intricate challenges and opportunities in designing and developing advanced medical devices. With an MBA from the Rady School of Management and a BS in Engineering Physics from UC San Diego, Matt brings a unique blend of technical engineering expertise and strategic business insight to every challenge. Excited to see the continued impact Matt will have on the future of infusion device innovation! ?#Leadership #Innovation #CEO #MedTech

As we prepare for?#LSIUSA25, we are excited to announce that Matthew S. Morris, our newly appointed CEO at Altra, will be presenting our latest advancements in infusion therapy at the esteemed LSI conference in Dana Point, California. Inspired by the human heart, our innovative dual-chamber pumping technology is designed to enhance safety and efficacy in drug delivery, addressing critical challenges in infusion therapy. This platform aims to significantly reduce adverse events, representing a major breakthrough for both patients and healthcare providers We are also getting ready to open our first round of investment and would love to hear from angel investment funds and venture capital groups interested in our technology. We welcome the opportunity to connect with us and learn more about Altra at LSI!

We’re thrilled to introduce our third and final co-founder, Marco Schilling. With over 40 years of mechanical design and engineering expertise, Marco has been instrumental in shaping Altra's technical development. As the founder of a renowned medical design consulting company that thrived for 35 years, Marco brings specialized skills in intricate surfacing, computer-aided design, assembly for manufacture, finite element analysis, and cost reduction strategies. His profound understanding of the complexities within the medical field allows him to consistently deliver innovative solutions that elevate patient care and advance medical technology. We’re incredibly fortunate to have Marco on board, continuing his journey of technical leadership and commitment to excellence at Altra. #Infusion #MedicalDevices #Innovation #Engineering #HealthcareInnovation #Founders

It’s been over 30 years since the introduction of the first cassette and peristaltic pumping systems, yet significant breakthroughs in large volume parenteral pumping mechanisms have been few and far between. While we’ve seen incremental improvements, the fundamental pumping mechanisms remain unchanged. This stagnation means that many inherent weaknesses persist, particularly when it comes to handling high fluid viscosities, accommodating varied infusion rates, and managing different use conditions. At Altra, we’re committed to driving innovation in this space. With 4 utility patents issued and 2 pending with international coverage in 19 countries. Our core patent has been defined as a?pure invention?by the USPTO. Not even Edison's lightbulb shares this designation. We believe it's crucial to push for transformative innovations that redefine the standards for LVP pumping mechanisms, driving meaningful change across the industry. #MedicalDevices #MedTech #Innovation #HealthcareTechnology #InfusionPumps #PatientCare

Honored to recognize Kimberly Morris, co-founder and majority owner of Altra, Inc. With over 25 years as a medical and surgical nurse, Kimberly has an in-depth understanding of what’s essential for patient care. After retiring, she continued her dedication by volunteering for more than a decade at Rady Children’s Hospital. When her husband, a 40+ year veteran of the infusion industry, came to her with the idea for an innovative IV pump, Kimberly’s deep insights into the needs of nurses and patients immediately revealed its transformative potential. Her unwavering support has been instrumental in advancing this technology at Altra, driving improvements for both patient outcomes and the healthcare professionals who serve them. #MedTechInnovation #NurseLeadership #HealthcareAdvocate #WomenInMedTech

We are thrilled to announce that we have been selected for the prestigious Aspire MedTech Program, starting October 15th! Over the course of five weeks, we’ll be working closely with investor-mentors from across the country, refining our materials and stress-testing our business as we prepare to raise equity investment. The Aspire program will simulate real investor due diligence conversations, helping us to integrate feedback in real-time and strengthening our deal room materials. We are honored to be part of a program that recognizes our potential to solve critical healthcare challenges. This opportunity will not only prepare us for upcoming investment rounds, but will also allow us to engage with other innovative MedTech startups and early-stage financing experts. Stay tuned for updates as we work towards bringing meaningful change to infusion therapy! #MedTech #Innovation #AspireMedTech #Healthcare #InfusionTherapy

Meet Matthew Morris, one of Altra’s three co-founders and the inventor of its technology. With over 40 years of extensive experience in Class II medical devices and infusion systems, Matthew has worked with some of the industry's largest companies. He has an impressive track record, having led product releases that account for over 50% of the domestic market. Matthew holds 18 utility patents, with 3 additional patent applications pending. He completed an MBA from SDSU and a BS in Physics from Stevens Institute of Technology, combining technical expertise with strategic business acumen to drive impactful advancements in healthcare. #MedTech #HealthTech #InfusionPumps